SKP2 and breast cancer: It integrates computational, in vitro, and in vivo evidence to demonstrate that fascin promotes BC cell cycle progression—at least in part—by upregulating SKP2 and downregulating its inhibitory targets, p27 and p21, thereby facilitating the G1-to-S-phase transition.